A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children
Clinical trial NCT05099029 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05099029
- Sponsor
- Enimmune Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-27
- Primary completion
- 2024-08-30
- Enrollment
- 3982
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.